Statement from ONDCP Director Dr. Rahul Gupta Regarding White House Meeting on Increasing Access and Affordability of FDA-Approved Overdose Reversal Medications June 20, 2023 • Press Releases
ONDCP Director Dr. Gupta Visits West Virginia to Meet with Leaders on the Front Lines of the Overdose Epidemic June 13, 2023 • Press Releases
Joint Statement on the North American Drug Dialogue Public Health Summit June 08, 2023 • Press Releases
Readout of WADA Executive Committee Meeting as USA Participates as Member for First Time Since 2015 May 11, 2023 • Press Releases
ONDCP Director Dr. Rahul Gupta Visits St. Paul and Minneapolis to Meet with Leaders on the Front Lines of the Overdose Epidemic May 08, 2023 • Press Releases
NEJM Publishes ONDCP Op-ed on the Medical and Public Health Imperatives Surrounding Xylazine, which Dr. Gupta Designated as an Emerging Drug Threat to the Nation April 26, 2023 • Press Releases
In Philadelphia, ONDCP Director Meets with Leaders on the Front Lines of Fentanyl and Xylazine Crisis April 24, 2023 • Press Releases
United States Elected to the Presidency of the American Sports Council, Will Serve on the World Anti-Doping Agency’s Executive Committee April 19, 2023 • Press Releases
ONDCP Director Statement on New CMS Guidance to Increase Access to Addiction Treatment in Carceral Facilities April 17, 2023 • Press Releases
